Targeted therapies: tailored treatment for ovarian cancer: are we there yet?

Nat Rev Clin Oncol. 2010 Feb;7(2):80-2. doi: 10.1038/nrclinonc.2009.233.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bridged-Ring Compounds / therapeutic use
  • Disease-Free Survival
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Platinum / therapeutic use
  • Taxoids / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • Taxoids
  • taxane
  • Platinum